YOU ARE HERE: Home>>Product>>Classified By Ratio/Standard>>Standard Extract>>

Galanthamine Hydrobromide Lycoremine

  • Galanthamine
  • Galanthamine
  • Galanthamine

Galanthamine Hydrobromide Lycoremine

  • CAS NO.: 1953-04-4
  • Main Contents: galantamine hydrobromide; Galantamine Hbr; galanthamine hydrobromide
  • Plant Resource.: Lycoris radiata (LHer.) Herb.
  • Main Specification: 99%
  • Appearance: White to whitish crystal powder, odorless and tasteless.
  • Plant Part Used: Tuber
  • Extract Solution: Hydro-alcoholic extraction
  • Molecular formula and weight: C17H21NO3.HBr;C17H22BrNO3  Molecular weight:368.27

  • Extract Solution: HPLC
  • Contact Us
    Product Description

    Galanthamine extract is specific, competitive and reversible acetylcholinesterase inhibitor. It is also an allosteric modulator at nicotinic cholinergic receptor sites potentiating cholinergic nicotinic neurotransmission. Both the acetylcholine and nicotine receptors have been suggested as areas related to cognitive impairment. Initially, Galanthamine extract was used in anesthesiology to antagonize the effects of non-depolarizing muscle relaxants, and since then it was rapidly introduced in other areas of medicine, i.e. neurology, ophthalmology, gastroenterology, intensive care and resuscitation, cardiology, physiotherapy.
        Galanthamine extract is a product with broad therapeutic index, allowing "soft" manifestation of its effect with individual dosing depending on the particular case. Several trials already showed that Galantamine 16 and 24 mg/day significantly benefits the cognitive, functional, and behavioral symptoms of AD as compared with placebo and proved also to be very effective in symptomatic treatment of senile dementia of Alzheimer's type
        Galanthamine marketed under the name of Reminyl by Johnson & Johnson's Belgian subsidiary, Janssen Pharmaceutica and Britain's Shire Pharmaceuticals, is licensed for the treatment of mild to moderately severe Alzheimer's disease, and was launched in September 2000 and approved by FDA in Feb.2001.
        Now, Galanthamine has received regulatory approval in 29 counties: Argentina, Australia, Canada, Czechia, the Europ

    Benefits
    Galanthamine extract is specific, competitive and reversible acetylcholinesterase inhibitor. It is also an allosteric modulator at nicotinic cholinergic receptor sites potentiating cholinergic nicotinic neurotransmission. Both the acetylcholine and nicotine receptors have been suggested as areas related to cognitive impairment. Initially, Galanthamine extract was used in anesthesiology to antagonize the effects of non-depolarizing muscle relaxants, and since then it was rapidly introduced in other areas of medicine, i.e. neurology, ophthalmology, gastroenterology, intensive care and resuscitation, cardiology, physiotherapy.
    Application
    •Anesthesiology • use for neurology • Use for ophthalmology • Use for gastroenterology, intensive care and resuscitation, cardiology, physiotherapy
    Net Weight
    25kgs/drum
    Packing Detail
    Packed in paper-drums and two plastic-bags inside. Net Weight: 25kgs/drum. I.D.
    Shelf Life
    two years under well Storage situation and stored away from direct sun light.
    Storage Situation
    Stored in a cool and dry well-closed container, keep away from moisture and strong light / heat.

    Galantamine,Hydrobromide,Lycor
    Related Products